Back
Corcept Therapeutics Vs. Akebia Therapeutics Industry Stock Comparison
Buy
62
CORT
Corcept Therapeutics
Last Price:
$51.46
Seasonality Move:
11.1%
Sell
39
AKBA
Akebia Therapeutics
Last Price:
$1.84
Seasonality Move:
7.91%
Buy
62
Corcept Therapeutics (CORT)
is a Buy
Is Corcept Therapeutics a Buy, Sell or Hold?
-
The current Corcept Therapeutics [CORT] share price is $51.43. The Score for CORT is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
CORT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Akebia Therapeutics (AKBA)
is a Sell
Is Akebia Therapeutics a Buy, Sell or Hold?
-
The current Akebia Therapeutics [AKBA] share price is $1.84. The Score for AKBA is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
AKBA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CORT Stock Price Chart
What is Corcept Therapeutics's stock price today?
-
The Corcept Therapeutics share price today is $51.43Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CORT is experiencing slight buying pressure.
AKBA Stock Price Chart
What is Akebia Therapeutics's stock price today?
-
The Akebia Therapeutics share price today is $1.84The current trend is relatively stagnant and AKBA is experiencing slight buying pressure.
CORT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.35 | Sell |
Relative Strength Index (14 RSI): | 37.6 | Sell |
Chaikin Money Flow: | 513952 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (53.71 - 59.69) | Sell |
Bollinger Bands (100): | (36.75 - 54.85) | Buy |
AKBA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0 | Sell |
Relative Strength Index (14 RSI): | 46.96 | Sell |
Chaikin Money Flow: | 2456900 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.81 - 2.03) | Sell |
Bollinger Bands (100): | (1.31 - 1.85) | Buy |
CORT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 54.67 | Sell |
20-day SMA: | 57.34 | Sell |
50-day SMA: | 53.53 | Sell |
200-day SMA: | 36.92 | Buy |
8-day EMA: | 54.09 | Sell |
20-day EMA: | 55.57 | Sell |
50-day EMA: | 52.97 | Sell |
200-day EMA: | 40.7 | Buy |
AKBA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.84 | Sell |
20-day SMA: | 1.95 | Sell |
50-day SMA: | 1.79 | Buy |
200-day SMA: | 1.45 | Buy |
8-day EMA: | 1.85 | Sell |
20-day EMA: | 1.88 | Sell |
50-day EMA: | 1.79 | Buy |
200-day EMA: | 1.5 | Buy |
Corcept Therapeutics Earnings Growth & CORT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.43 per share, and an increase next year of $0.32 per share.
Akebia Therapeutics Earnings Growth & AKBA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and an increase next year of $0.07 per share.
Corcept Therapeutics Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akebia Therapeutics Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |